The eMESH 1 Feasibility Study
Phase 1
- Conditions
- Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)
- Interventions
- Device: eSVS Mesh treated saphenous vein graftOther: Control saphenous vein graft
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2015-02-19
- Lead Sponsor
- Kips Bay Medical, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT01676376
- Locations
- 🇨🇿
Hospital na Homolce, Prague, Czech Republic
🇨ðŸ‡University Hospital of Bern, Bern, Switzerland
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
The eSVS® Mesh Post-Marketing Trial
Not Applicable
Terminated
- Conditions
- Myocardial IschemiaHeart DiseasesArterial Occlusive DiseasesCoronary Artery DiseaseCoronary DiseaseArteriosclerosisCardiovascular DiseasesVascular Diseases
- Interventions
- Device: eSVS Mesh
- First Posted Date
- 2012-01-27
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Kips Bay Medical, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01520311
- Locations
- 🇨ðŸ‡
University Hospital, Basel, Switzerland
The eSVS® Mesh Randomized Post-Market Study
Not Applicable
Terminated
- Conditions
- Coronary Artery DiseaseMyocardial IschemiaCoronary DiseaseCardiovascular DiseasesHeart DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases
- Interventions
- Device: eSVS® Mesh
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2014-02-28
- Lead Sponsor
- Kips Bay Medical, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01462721
- Locations
- 🇩🇪
University Hospital of Kiel, Kiel, Germany
© Copyright 2025. All Rights Reserved by MedPath